These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1187 related items for PubMed ID: 28057194
1. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization. Khan MM, Sharma S, Tripathi B, Alvarez FP. Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194 [Abstract] [Full Text] [Related]
10. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Wattigney WA, Mootrey GT, Braun MM, Chen RT. Pediatrics; 2001 May 11; 107(5):E83. PubMed ID: 11331733 [Abstract] [Full Text] [Related]
11. Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014. Liu Y, Wang J, Liu S, Du J, Wang L, Gu W, Xu Y, Zuo S, Xu E, An Z. Vaccine; 2017 Mar 01; 35(9):1281-1286. PubMed ID: 28161421 [Abstract] [Full Text] [Related]
12. Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program. Domingues CM, de Fátima Pereira S, Cunha Marreiros AC, Menezes N, Flannery B. J Infect Dis; 2014 Nov 01; 210 Suppl 1(0 1):S143-51. PubMed ID: 25316829 [Abstract] [Full Text] [Related]
13. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China. Li R, Li CG, Li Y, Liu Y, Zhao H, Chen X, Kuriyakose S, Van Der Meeren O, Hardt K, Hezareh M, Roy-Ghanta S. Vaccine; 2016 Mar 14; 34(12):1436-43. PubMed ID: 26873055 [Abstract] [Full Text] [Related]
16. Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis - Beijing, China, 2014-2016. Zhao D, Ma R, Zhou T, Yang F, Wu J, Sun H, Liu F, Lu L, Li X, Zuo S, Yao W, Yin J. MMWR Morb Mortal Wkly Rep; 2017 Dec 15; 66(49):1357-1361. PubMed ID: 29240729 [Abstract] [Full Text] [Related]
17. Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. Miller MA, Sutter RW, Strebel PM, Hadler SC. JAMA; 1996 Sep 25; 276(12):967-71. PubMed ID: 8805731 [Abstract] [Full Text] [Related]
18. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation. Duintjer Tebbens RJ, Thompson KM. J Infect Dis; 2014 Nov 01; 210 Suppl 1():S485-97. PubMed ID: 25316871 [Abstract] [Full Text] [Related]
19. Coverage estimates and patterns of inactivated poliovirus vaccine (IPV) use prior to and during the polio eradication endgame, Jinan City, China, 2010-2015. Chang C, Zhang J, Zhou J, Cao R, Song K, Liu C, Zhang X, Geng X, Liu X, Li C. Hum Vaccin Immunother; 2016 Nov 01; 12(11):2749-2752. PubMed ID: 27437792 [Abstract] [Full Text] [Related]